Reducing Maternal Depression & Promoting Infant Social-Emotional Health &

Status Completed

Clinical Trial Summary

A mobile remote coaching program study to improve maternal mood and increase parenting practices that lead to better infant social-emotional and communication outcomes

Clinical Trial Description

To address the life course needs of depressed mothers and their infants, brief, accessible, and integrated interventions that target both maternal depression and specific nurturing parent behaviors demonstrated to improve infant social-emotional communication outcomes are needed. In prior programmatic research, two separate web-based, remote coaching interventions for: (a) parent nurturing behaviors that improve infant outcomes (Baby-Net R34; R01) [13], and (b) maternal depression (Mom-Net R34; R01) [14] were developed. Compared to controls, the Baby-Net program demonstrated medium to large effects on observed nurturing parent behavior and on infant social-emotional competencies in the context of play [13] and in the context of book activities [15]. Mom-Net demonstrated low attrition and high levels of feasibility, program use, and satisfaction [14]. Compared to controls, Mom-Net participants demonstrated significant reductions in depression and improved preschool parenting behavior [14]. A substantial advantage of the mobile, remote coaching approach is that it overcomes multiple logistical barriers that often prevent low-income mothers from participating in community/home visiting treatment programs [2]. Thus, this prior research on web-based maternal depression and specific nurturing parenting behavior in infancy, provides a strong empirical basis for the Mom & Baby Net program. Investigators will rigorously test the merged Mom & Baby Net intervention effects with a total sample of 368 participants (184 mothers with depression and 184 infants) via a 2-arm, intent-to-treat, randomized controlled trial. The start date of this grant-funded randomized controlled trial was September 1, 2016. Data collection is currently underway and scheduled to conclude in March 2022. Following IRB-approved pilot work, the randomized controlled trial was IRB- approved on November 17, 2017. Immediately following IRB approval, recruitment was initiated. Between February 15, 2018 and March 11, 2021, we successfully consented a total sample of 368 participants (184 women and 184 infants) into the randomized controlled trial. The sample is predominantly Black and socioeconomically disadvantaged. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03464630
Study type	Interventional
Source	Georgia State University
Contact
Status	Completed
Phase	N/A
Start date	February 15, 2018
Completion date	July 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05793112` - INF108F in Infants With Food Protein Induced Proctocolitis	Phase 4
Recruiting	`NCT03828708` - Early Iron Exposure on the Gut Microbiota in Young Infants	N/A
Recruiting	`NCT06018064` - Investigating Fit and Satisfaction of the Prone Positioner	N/A
Not yet recruiting	`NCT06335524` - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants	N/A
Not yet recruiting	`NCT05039918` - Neonatal Experience of Social Touch	N/A
Completed	`NCT01166867` - A Pilot Study Using Photo-plethysmographic (PPG) Camera
Completed	`NCT00791466` - Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development	N/A
Completed	`NCT03331276` - Growth and Safety Study of an Infant Formula for Healthy Term Infants	N/A
Completed	`NCT05157633` - Oral Exploration of Objects and Food Diversification
Completed	`NCT05217186` - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Recruiting	`NCT05006989` - Blueberry Intake and Infant Gut Health	N/A
Completed	`NCT04901611` - Parental Touch Trial (Petal)	N/A
Completed	`NCT03082313` - Movement-based Infant Intervention	N/A
Recruiting	`NCT06053515` - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication	N/A
Completed	`NCT05394883` - The SPROUT (Pilot) Project	N/A
Completed	`NCT03991949` - Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula	N/A
Active, not recruiting	`NCT03851120` - Brain Probiotic and LC-PUFA Intervention for Optimum Early Life	Phase 2
Completed	`NCT03662048` - Improving Infant Sleep Safety With the Electronic Health Record	N/A
Active, not recruiting	`NCT04749888` - Impact of the Korea Early Childhood Home-visiting Intervention	N/A
Recruiting	`NCT06230848` - Multisensory Early Oral Administration of Human Milk in Preterm Infants	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Reducing Maternal Depression and Promoting Infant Social-Emotional Health & Development — MBN

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms